Medication management for feline HCM using diuretics, antiplatelet agents, and other drugs requires regular monitoring to maintain effectiveness while minimising drug-related welfare costs.
HCM medication management requires precise calibration to provide welfare benefit without causing drug-related harm. Furosemide underdosing allows fluid accumulation causing respiratory distress; overdosing causes dehydration and renal damage. Both represent welfare costs from medication mismanagement. Regular monitoring guided by home respiratory rate tracking enables timely dose adjustments before either problem becomes severe. Clopidogrel provides welfare protection against the catastrophic event of arterial thromboembolism in high-risk cats. The combination of appropriate medication, regular monitoring, and responsive dose adjustment represents optimal welfare management for HCM cats in congestive heart failure.